Von Willebrand disease type 2M: Correlation between genotype and phenotype. (21st November 2021)

• Record Type: Journal Article
• Authors: Maas, Dominique P. M. S. M.; Atiq, Ferdows; Blijlevens, Nicole M. A.; Brons, Paul P. T.; Krouwel, Sandy; Laros‐van Gorkom, Britta A. P.; Leebeek, Frank W. G.; Nieuwenhuizen, Laurens; Schoormans, Selene C. M.; Simons, Annet; Meijer, Daniëlle; van Heerde, Waander L.; Schols, Saskia E. M.
• Is Part Of: Journal of thrombosis and haemostasis. Volume 20:Number 2(2022)
• Page Start: 316
• Page End: 327
• Publication Date: 2021-11-21
• Subjects: genotype -- hemorrhage -- hemostasis -- phenotype -- von Willebrand disease, type 2; Thrombosis -- Periodicals; Hemostasis -- Periodicals; Blood coagulation disorders -- Periodicals; 616.1
• DOI: 10.1111/jth.15586
• Languages: English
• ISSNs: 1538-7933

Abstract

Abstract: Background: An appropriate clinical diagnosis of von Willebrand disease (VWD) can be challenging because of a variable bleeding pattern and laboratory phenotype. Genotyping is a powerful diagnostic tool and may have an essential role in the diagnostic field of VWD. Objectives: To unravel the clinical and laboratory heterogeneity of genetically confirmed VWD type 2M patients and to investigate their relationship. Methods: Patients with a confirmed VWD type 2M genetic variant in the A1 or A3 domain of von Willebrand factor (VWF) and normal or only slightly aberrant VWF multimers were selected from all subjects genotyped at the Radboud university medical center because of a high suspicion of VWD. Bleeding scores and laboratory results were analyzed. Results: Fifty patients had a clinically relevant genetic variant in the A1 domain. Median bleeding score was 5. Compared with the nationwide Willebrand in the Netherlands study type 2 cohort, bleeding after surgery or delivery was reported more frequently and mucocutaneous bleedings less frequently. Median VWF activity/VWF antigen (VWF:Act/VWF:Ag) ratio was 0.32, whereas VWF collagen binding activity/VWF antigen (VWF:CB/VWF:Ag) ratio was 0.80. Variants in the A3 domain were only found in two patients with low to normal VWF:Act/VWF:Ag ratios (0.45, 1.03) and low VWF:CB/VWF:Ag ratios (0.45, 0.63). Conclusion: Genetically confirmed VWD type 2M patients have a relatively mild clinical phenotype, except for bleeding after surgery and delivery. Laboratory phenotype is variable and depends on the underlying genetic variant. Addition of genotyping to the current phenotypic characterization may improve diagnosis and classification of VWD.